blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1476423

EP1476423 - ARYLSULFONAMIDOBENZYLIC COMPOUNDS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  21.08.2009
Database last updated on 02.11.2024
Most recent event   Tooltip30.09.2011Lapse of the patent in a contracting state
New state(s): CY, TR		published on 02.11.2011  [2011/44]
Applicant(s)For all designated states
Amgen Inc.
One Amgen Center Drive
Thousand Oaks, CA 91320-1799 / US
[2008/01]
Former [2004/47]For all designated states
Tularik Inc.
Two Corporate Drive
South San Francisco, CA 94080 / US
Inventor(s)01 / JIAO, Xian, Yun
1738 South Grant Street, Apt. 5
San Mateo, CA 94402 / US
02 / KAYSER, Frank
4150 17th Street, 25
San Francisco, CA 94114 / US
03 / KOPECKY, David, J.
788 Harrison Street, Apt. 507
San Francisco, CA 94107 / US
04 / MCKENDRY, Sharon
231 30th Street
San Francisco, CA 94131 / US
05 / PIPER, Derek, E.
345 Stanchion Lane
Foster City, CA 94404 / US
06 / SHIAU, Andrew, K.
34 Hugo Street, Apt. 3
San Francsico, CA 94122 / US
 [2004/47]
Representative(s)Thomson, Paul Anthony
Potts, Kerr & Co. 15, Hamilton Square Birkenhead
Merseyside CH41 6BR / GB
[N/P]
Former [2004/47]Thomson, Paul Anthony
Potts, Kerr & Co. 15, Hamilton Square
Birkenhead Merseyside CH41 6BR / GB
Application number, filing date03735124.429.01.2003
[2004/47]
WO2003US03149
Priority number, dateUS20020353497P30.01.2002         Original published format: US 353497 P
[2004/47]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO03063576
Date:07.08.2003
Language:EN
[2003/32]
Type: A2 Application without search report 
No.:EP1476423
Date:17.11.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 07.08.2003 takes the place of the publication of the European patent application.
[2004/47]
Type: B1 Patent specification 
No.:EP1476423
Date:15.10.2008
Language:EN
[2008/42]
Search report(s)International search report - published on:US31.12.2003
(Supplementary) European search report - dispatched on:EP28.10.2005
ClassificationIPC:C07C311/08, C07C311/13, C07C311/15, C07C311/16, C07C311/20, C07C311/21, A61K31/18, A61K31/625, A61K31/63, A61P3/04, A61P3/06, C07D207/32, C07D213/30, C07D231/12, C07D233/54, C07D235/12, C07D239/26, C07D257/04, C07D277/24, C07D333/34, C07F7/08
[2005/50]
CPC:
C07D207/33 (EP,US); A61P3/04 (EP); A61P3/06 (EP);
A61P3/10 (EP); A61P35/04 (EP); A61P43/00 (EP);
A61P9/10 (EP); C07C311/21 (EP,US); C07C317/32 (EP,US);
C07D207/333 (EP,US); C07D207/335 (EP,US); C07D213/30 (EP,US);
C07D213/42 (EP,US); C07D231/12 (EP,US); C07D233/61 (EP,US);
C07D233/64 (EP,US); C07D235/12 (EP,US); C07D235/14 (EP,US);
C07D239/26 (EP,US); C07D257/04 (EP,US); C07D277/24 (EP,US);
C07D277/28 (EP,US); C07D333/34 (EP,US); C07F7/081 (EP,US);
C07C2601/08 (EP,US); C07C2601/16 (EP,US) (-)
Former IPC [2004/47]C07C311/08, C07C311/13, C07C311/15, C07C311/16, C07C311/20, C07C311/21, A61K31/18, A61K31/625, A61K31/63, A61P3/04, A61P3/06
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SI,   SK,   TR [2004/47]
Extension statesAL13.08.2004
LT13.08.2004
LV13.08.2004
MK13.08.2004
RO13.08.2004
TitleGerman:ARYLSULFONAMIDOBENZYLVERBINDUNGEN[2004/47]
English:ARYLSULFONAMIDOBENZYLIC COMPOUNDS[2004/47]
French:COMPOSES ARYLSULFONAMIDOBENZYLIQUES[2004/47]
Entry into regional phase13.08.2004National basic fee paid 
13.08.2004Search fee paid 
13.08.2004Designation fee(s) paid 
13.08.2004Examination fee paid 
Examination procedure08.08.2003Request for preliminary examination filed
International Preliminary Examining Authority: US
13.08.2004Examination requested  [2004/47]
02.10.2006Despatch of a communication from the examining division (Time limit: M04)
18.01.2007Reply to a communication from the examining division
07.08.2007Despatch of a communication from the examining division (Time limit: M04)
14.11.2007Reply to a communication from the examining division
21.04.2008Communication of intention to grant the patent
09.08.2008Fee for grant paid
09.08.2008Fee for publishing/printing paid
Opposition(s)16.07.2009No opposition filed within time limit [2009/39]
Fees paidRenewal fee
12.01.2005Renewal fee patent year 03
12.01.2006Renewal fee patent year 04
12.01.2007Renewal fee patent year 05
14.01.2008Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT15.10.2008
BE15.10.2008
CY15.10.2008
CZ15.10.2008
DK15.10.2008
EE15.10.2008
FI15.10.2008
NL15.10.2008
SI15.10.2008
SK15.10.2008
TR15.10.2008
BG15.01.2009
SE15.01.2009
GR16.01.2009
IE29.01.2009
LU29.01.2009
MC31.01.2009
PT16.03.2009
HU16.04.2009
[2011/43]
Former [2011/31]AT15.10.2008
BE15.10.2008
CZ15.10.2008
DK15.10.2008
EE15.10.2008
FI15.10.2008
NL15.10.2008
SI15.10.2008
SK15.10.2008
BG15.01.2009
SE15.01.2009
GR16.01.2009
IE29.01.2009
LU29.01.2009
MC31.01.2009
PT16.03.2009
HU16.04.2009
Former [2011/21]AT15.10.2008
BE15.10.2008
CZ15.10.2008
DK15.10.2008
EE15.10.2008
FI15.10.2008
NL15.10.2008
SI15.10.2008
SK15.10.2008
BG15.01.2009
SE15.01.2009
GR16.01.2009
IE29.01.2009
LU29.01.2009
MC31.01.2009
PT16.03.2009
Former [2010/48]AT15.10.2008
BE15.10.2008
CZ15.10.2008
DK15.10.2008
EE15.10.2008
FI15.10.2008
NL15.10.2008
SI15.10.2008
SK15.10.2008
BG15.01.2009
SE15.01.2009
GR16.01.2009
IE29.01.2009
MC31.01.2009
PT16.03.2009
Former [2010/07]AT15.10.2008
BE15.10.2008
CZ15.10.2008
DK15.10.2008
EE15.10.2008
FI15.10.2008
NL15.10.2008
SI15.10.2008
SK15.10.2008
BG15.01.2009
SE15.01.2009
IE29.01.2009
MC31.01.2009
PT16.03.2009
Former [2009/43]AT15.10.2008
BE15.10.2008
CZ15.10.2008
DK15.10.2008
EE15.10.2008
FI15.10.2008
NL15.10.2008
SI15.10.2008
SK15.10.2008
BG15.01.2009
SE15.01.2009
MC31.01.2009
PT16.03.2009
Former [2009/39]AT15.10.2008
BE15.10.2008
CZ15.10.2008
DK15.10.2008
EE15.10.2008
FI15.10.2008
NL15.10.2008
SI15.10.2008
BG15.01.2009
SE15.01.2009
MC31.01.2009
PT16.03.2009
Former [2009/36]AT15.10.2008
BE15.10.2008
DK15.10.2008
EE15.10.2008
FI15.10.2008
NL15.10.2008
SI15.10.2008
BG15.01.2009
PT16.03.2009
Former [2009/34]AT15.10.2008
BE15.10.2008
DK15.10.2008
FI15.10.2008
NL15.10.2008
SI15.10.2008
BG15.01.2009
PT16.03.2009
Former [2009/32]AT15.10.2008
BE15.10.2008
FI15.10.2008
NL15.10.2008
SI15.10.2008
BG15.01.2009
PT16.03.2009
Former [2009/26]AT15.10.2008
FI15.10.2008
NL15.10.2008
SI15.10.2008
BG15.01.2009
PT16.03.2009
Former [2009/23]AT15.10.2008
BG15.01.2009
Documents cited:Search[A]WO0046203  (MILLENNIUM PHARM INC [US]) [A] 1-36* claim - *
International search[X]US6316503  (LI LEPING [US], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.